title: Nitroheterocyclic compounds as radiation sensitizers and bioreductive drugs.
authors.affiliation: Medical Research Council, Radiobiology Unit, Chilton, Didcot, Oxon, U.K.
authors.forename: G E
authors.initials: GE
authors.lastname: Adams
authors.forename: I J
authors.initials: IJ
authors.lastname: Stratford
authors.forename: J C
authors.initials: JC
authors.lastname: Bremner
authors.forename: H S
authors.initials: HS
authors.lastname: Edwards
authors.forename: E M
authors.initials: EM
authors.lastname: Fielden
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D006801:Humans; D008920:Misonidazole / Q000031:analogs & derivatives* / Q000627:therapeutic use; D009369:Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D009593:Nitroimidazoles / Q000627:therapeutic use*; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D009593:Nitroimidazoles; D011838:Radiation-Sensitizing Agents; C067834:RB 6145; C041712:1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol; D008920:Misonidazole